K. Mamiya

发表

Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non‐linear Mixed Effects Model approach

E. Yukawa, K. Mamiya, 2006, Journal of clinical pharmacy and therapeutics.

CYP2C19 polymorphism effect on phenobarbitone

E. Yukawa, S. Higuchi, N. Tashiro, 2000, European Journal of Clinical Pharmacology.

Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics

E. Yukawa, S. Higuchi, N. Tashiro, 2000 .

Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis.

S. Higuchi, N. Tashiro, I. Ieiri, 2000, Therapeutic drug monitoring.

Lithium concentration correlates with QTc in patients with psychosis.

E. Yukawa, H. Yao, K. Mamiya, 2005, Journal of electrocardiology.

P-Hydroxylation of Phenobarbital: Relationship to (s)-Mephenytoin Hydroxylation (CYP2C19) Polymorphism

S. Higuchi, N. Tashiro, I. Ieiri, 2001, Therapeutic drug monitoring.

CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese patients with epilepsy: analysis by population pharmacokinetics.

E. Yukawa, S. Higuchi, N. Tashiro, 2000, European journal of clinical pharmacology.

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.

S. Higuchi, I. Ieiri, A. Urae, 1998, Therapeutic drug monitoring.

Phenytoin intoxication induced by fluvoxamine.

E. Yukawa, S. Higuchi, N. Tashiro, 2001, Therapeutic drug monitoring.

The Effects of Genetic Polymorphisms of CYP2C9 and CYP2C 19 on Phenytoin Metabolism in Japanese Adult Patients with Epilepsy: Studies in Stereoselective Hydroxylation and Population Pharmacokinetics

E. Yukawa, S. Higuchi, N. Tashiro, 1998, Epilepsia.

Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese.

S. Higuchi, N. Tashiro, I. Ieiri, 1997, British journal of clinical pharmacology.

Synergistic Effect of Valproate Coadministration and Hypoalbuminemia on the Serum-Free Phenytoin Concentration in Patients With Severe Motor and Intellectual Disabilities

E. Yukawa, K. Mamiya, Takashi Matsumoto, 2002, Clinical neuropharmacology.

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy.

S. Higuchi, I. Ieiri, A. Urae, 1999, British journal of clinical pharmacology.

Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication.

S. Higuchi, N. Tashiro, I. Ieiri, 2000, Therapeutic drug monitoring.

Genetic polymorphisms and functional characterization of the 5′‐flanking region of the human CYP2C9 gene: In vitro and in vivo studies

S. Higuchi, N. Tashiro, I. Ieiri, 2001, Clinical pharmacology and therapeutics.

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.

E. Nanba, S. Higuchi, Y. Fukumaki, 2000, Pharmacogenetics.

A CYP2D6 phenotype-genotype mismatch in Japanese psychiatric patients.

S. Higuchi, N. Tashiro, I. Ieiri, 2004, Pharmacopsychiatry.

Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients.

S. Higuchi, Y. Fukumaki, N. Tashiro, 1998, Pharmacogenetics.